Key stats
About Amundi Index Solutions - Amundi Nyse Arca Gold Bugs
Home page
Inception date
Dec 7, 2023
Structure
Luxembourg SICAV
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Amundi Luxembourg SA
ISIN
LU2611731824
To track the performance of NYSE Arca Gold BUGS Index (the Index), and to minimize the tracking err between the net asset value of the sub-fund and the performance of the Index
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Non-Energy Minerals
Stocks100.00%
Non-Energy Minerals100.00%
Bonds, Cash & Other0.00%
Stock breakdown by region
North America89.25%
Africa6.40%
Latin America2.25%
Europe2.10%
Asia0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
CD91 top holdings are Agnico Eagle Mines Limited and Newmont Corporation, occupying 15.10% and 14.81% of the portfolio correspondingly.
CD91 last dividends amounted to 0.09 EUR. The year before, the issuer paid 0.51 EUR in dividends, which shows a 495.49% decrease.
CD91 assets under management is 570.12 M EUR. It's fallen 8.07% over the last month.
CD91 fund flows account for 8.74 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, CD91 pays dividends to its holders with the dividend yield of 0.16%. The last dividend (Dec 13, 2024) amounted to 0.09 EUR. The dividends are paid annually.
CD91 shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Dec 7, 2023, and its management style is Passive.
CD91 expense ratio is 0.65% meaning you'd have to pay 0.65% of your investment to help manage the fund.
CD91 follows the NYSE Arca Gold BUGS Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CD91 invests in stocks.
CD91 price has fallen by −4.12% over the last month, and its yearly performance shows a 67.35% increase. See more dynamics on CD91 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −3.38% over the last month, have fallen by −3.38% over the last month, showed a 35.41% increase in three-month performance and has increased by 65.22% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −3.38% over the last month, have fallen by −3.38% over the last month, showed a 35.41% increase in three-month performance and has increased by 65.22% in a year.
CD91 trades at a premium (0.46%) meaning the ETF is trading at a higher price than the calculated NAV.